EVerMed, Inc.
PrivateLast Round
Seed
Jan 28, 2025
Total Funding Raised
$2.94M
Company Overview
EVerMed, Inc. is a biotechnology company that develops extracellular vesicle (EV)-based therapeutics for intractable respiratory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EVerMed, Inc. Comparables
Compare EVerMed, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OmniSpirant Therapeutics | 84% | |
| EXORPHIA Inc. | 84% | |
| Evox Therapeutics | 77% |
EVerMed, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 28, 2025 |
EVerMed, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nissay Capital | Seed |
| WASEDA University Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 28, 2025
$3M round with Nissay Capital and WASEDA University Ventures
EVerMed, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about EVerMed, Inc.'s valuation, stock price, and market status.
Is EVerMed, Inc. a public or private company?
EVerMed, Inc. is a private company.
What is the current stock price of EVerMed, Inc.?
EVerMed, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is EVerMed, Inc. worth (valuation)?
Valuation information for EVerMed, Inc. is not publicly available.
Can I buy EVerMed, Inc. stock?
EVerMed, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was EVerMed, Inc.'s last funding round?
EVerMed, Inc.'s most recent funding round was Seed on January 28, 2025.
Who are the main investors in EVerMed, Inc.?
Key investors in EVerMed, Inc. include WASEDA University Ventures.
Will EVerMed, Inc. IPO soon?
No public IPO plans have been announced for EVerMed, Inc..
How can I track EVerMed, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor EVerMed, Inc.'s secondary market activity and sign up for updates.